Patent · US Active

Polymorphisms in the PDE3A gene

US9512481B2 · kind B2 · utility

0Cited by

98References

12Claims

0Family size

Assignee

The Regents of the University of Colorado, a Body Corporate · US

Inventors

Carmen Sucharov · Aurora, US
Michael Bristow · Englewood, US
Matthew Taylor · Denver, US
Dobromir Slavov · Aurora, US

Key dates

Filing date	Sep 13, 2010
Grant date	Dec 6, 2016
Priority date	—
Expiry date	Sep 13, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments of the invention are directed to identifying or treating a patient that would benefit from phosphodiesterase inhibitor therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.